{"id":"W4200600309","doi":"10.1111/1759-7714.14281","title":"Short‐term safety of an anti‐severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine for patients with advanced lung cancer treated with anticancer drugs: A multicenter, prospective, observational study","year":2021,"lang":"en","type":"article","venue":"Thoracic Cancer","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Chugai Pharmaceutical; Merck Sharp and Dohme; Bristol-Myers Squibb Canada; Ono Pharmaceutical; Shionogi; Nippon Shinyaku; Astellas Pharma; Boehringer Ingelheim; Nippon Kayaku; Daiichi Sankyo Company; Kyowa Kirin Pharmaceutical Development; Taiho Pharmaceutical; Celgene; Takeda Pharmaceutical Company; Novartis; Pfizer","keywords":"Medicine; Vaccination; Adverse effect; Lung cancer; Internal medicine; Cancer; Coronavirus; Chemotherapy; Immunology; Disease; Coronavirus disease 2019 (COVID-19)","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001619481,0.0003154339,0.00057381,0.0002828101,0.0003238648,0.0006075745,0.0002854717,0.0005263938,0.000761566],"category_scores_gemma":[0.002950577,0.0002295321,0.00124412,0.0005570658,0.0002622038,0.0004618367,0.0002796913,0.0007597922,0.0001302347],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004126351,"about_ca_system_score_gemma":0.0005216025,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001053325,"about_ca_topic_score_gemma":0.0008755645,"domain_scores_codex":[0.9989616,0.0003943116,0.0001463023,0.000211932,0.0001739626,0.0001118447],"domain_scores_gemma":[0.9950965,0.0009108877,0.002844429,0.0002773248,0.0003109669,0.0005599353],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00445245,0.0003350302,0.9918662,0.00004551308,0.0005865318,0.0000594047,0.00004178813,0.0001448189,0.0004640154,0.0000118805,0.0001553527,0.001837086],"study_design_scores_gemma":[0.0005881708,0.007435218,0.9899039,0.00002026699,0.0003975766,0.0002960472,0.00007803096,0.0006217568,0.000284601,0.00002185269,0.0003422101,0.00001042314],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9993629,0.0002426888,0.00005252999,0.00002571787,0.000004965594,0.00001699168,0.0002081786,0.000001328095,0.00008471731],"genre_scores_gemma":[0.9992472,0.00009043101,0.00004695944,0.00004431029,0.00001976873,0.00001862169,0.0004954833,7.611671e-7,0.0000364483],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001619481,"threshold_uncertainty_score":0.00856477,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04150831443297955,"score_gpt":0.3880192247875337,"score_spread":0.3465109103545542,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}